← Back to headlines
Rigel Pharmaceuticals Secures Breast Cancer Drug Deal with Arvinas and Pfizer
Rigel Pharmaceuticals has finalized an agreement with Arvinas and Pfizer concerning a new drug for breast cancer treatment.
15 May, 20:31 — 15 May, 20:31
Sources
Showing 1 of 1 sources
